Published in
2023
March 2023, Volume 176, Pages 115-120; doi: 10.1016/j.urology.2023.03.014
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA Tarik Benidir, Zaeem Lone, Andrew Wood, Nour Abdallah, Rebecca Campbell, Petar Bajic, Andrei Purysko, Jane K. Nguyen, Jihad Kaouk, Georges Pascal Haber, Mohamed Eltemamy, Robert Stein, Samuel Haywood, Eric A. Klein, Nima Almassi, Steven C. Campbell, Robert Abouassaly, and Christopher J. Weight
Objective
Methodology
To assess how IsoPSA, a structure-based serum assay which has been prospectively validated in detecting clinically significant prostate cancer (csPCa), can help the biopsy decision process when combined with the prostate imaging reporting and data systems (PI-RADS).
• Single-center (Cleveland Clinic) retrospective review of prospectively collected data from January 2019 to January 2021. • 207 patients who underwent prostate MRI, IsoPSA testing and biopsy.
Results
Conclusion
Risk of Clinically Significant Prostate Cancer IsoPSA ≤ 6
IsoPSA > 6
PI-RADS 1-2
2%
15%
PI-RADS 3
4.5%
16%
PI-RADS 4-5
19%
49%
The combination of IsoPSA with PI-RADS scores provides meaningful predicted probabilities for the likelihood of detecting csPCa at biopsy with a reassuringly low probability when PI-RADS 1 to 3 is found in conjunction with a low IsoPSA Index. Use of such prebiopsy adjuncts may provide an opportunity for shared decision making with patients on whether or not to conduct a prostate biopsy in men with initially elevated PSA.
IsoPSA ADDS CLARITY TO MRI Negative MRI (PI-RADS 1-2)
• 4-16% of PI-RADS 1-2 harbour csPCa • PI-RADS 1-2 with: – IsoPSA Index ≤ 6 = NPV 98% – IsoPSA Index > 6 = 8% predictive probability of finding csPCa on biopsy
Help assess risk of presence or absence of MRI-invisible csPCa
Equivocal MRI (PI-RADS 3)
• PI-RADS 3 with: – IsoPSA Index ≤ 6 = NPV 96% – IsoPSA Index > 6 = 16% predictive probability of finding csPCa on biopsy
Gain additional insight to triage patients
PATIENT MANAGEMENT PI-RADS 1-2 NEGATIVE
PI-RADS 3 EQUIVOCAL
PI-RADS 4-5 POSITIVE
IsoPSA Index ≤ 6
Reduces probability of csPCa Biopsy may not be needed
Reduces probability of csPCa Biopsy may not be needed
Biopsy regardless of IsoPSA Index
IsoPSA Index > 6
Consider Biopsy
Should Biopsy
Biopsy regardless of IsoPSA Index
View this and other IsoPSA publications
Learn more about IsoPSA at IsoPSA.com 3615 Superior Ave. Suite 4407C ©2023 Cleveland Diagnostics, IsoPSA and all associated logos are trademarks of Cleveland Diagnostics, Inc. MKTG-VSA003
Cleveland, OH 44114